| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0306-4522(96)00553-2 |
| P8608 | Fatcat ID | release_vmlku2otmnd4lcfkh7ycespqea |
| P698 | PubMed publication ID | 9135095 |
| P50 | author | Eliezer Masliah | Q28324209 |
| Carmela R Abraham | Q47844873 | ||
| Lennart Mucke | Q56825889 | ||
| P2093 | author name string | E M Rockenstein | |
| M Mallory | |||
| E Sheldon | |||
| C E Westland | |||
| I Veinberg | |||
| P2860 | cites work | Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein | Q22251280 |
| Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease | Q28241772 | ||
| Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine | Q28290906 | ||
| Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene | Q28586800 | ||
| beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity | Q28593175 | ||
| Axonal sprouting induced in the sciatic nerve by the amyloid precursor protein (APP) and other antiproteases. | Q31001104 | ||
| Amyloid precursor protein is localized in growing neurites of neonatal rat brain | Q33193350 | ||
| Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat | Q33321887 | ||
| Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. | Q34329828 | ||
| Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system | Q35270604 | ||
| Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor | Q35638734 | ||
| The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes | Q36198708 | ||
| Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures | Q36233456 | ||
| Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein | Q36364676 | ||
| Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. | Q36753784 | ||
| Neurotrophic and neuroprotective effects of hAPP in transgenic mice | Q36798319 | ||
| Protein inhibitors of proteinases from brain | Q36836252 | ||
| Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis | Q37351753 | ||
| Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth | Q38203041 | ||
| Biological differences between ischemia, hypoglycemia, and epilepsy | Q39550601 | ||
| HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists | Q40654337 | ||
| Alzheimer's disease: a central role for amyloid | Q40701623 | ||
| Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. | Q40717934 | ||
| Glial calcium | Q40781991 | ||
| Neurite outgrowth activity of protease nexin-1 on neuroblastoma cells requires thrombin inhibition | Q41223116 | ||
| Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury | Q41451125 | ||
| Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. | Q41710744 | ||
| Beta-amyloid precursor protein isoforms in various rat brain regions and during brain development | Q41966102 | ||
| The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. | Q43466747 | ||
| Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence | Q43536135 | ||
| Formation of beta-amyloid protein deposits in brains of transgenic mice | Q44671370 | ||
| Patterns of aberrant sprouting in Alzheimer's disease | Q45166469 | ||
| Spectrum of human immunodeficiency virus-associated neocortical damage | Q45871285 | ||
| Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor | Q46359315 | ||
| Reduction of neurological damage by a peptide segment of the amyloid beta/A4 protein precursor in a rabbit spinal cord ischemia model | Q46736730 | ||
| Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease | Q48069116 | ||
| Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein | Q48342880 | ||
| In vivo effects of beta-amyloid implants in rodents: lack of potentiation of damage associated with transient global forebrain ischemia | Q48454195 | ||
| Hippocampal damage produced by systemic injections of domoic acid in mice. | Q54083012 | ||
| Molecular Genetics of Alzheimer's Disease | Q56770140 | ||
| gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages | Q57616786 | ||
| Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice | Q60796700 | ||
| Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120 | Q67572030 | ||
| Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders | Q68268628 | ||
| Amyloid precursor protein gene mutation at codon 670/671 in familial Alzheimer's disease in Sweden | Q72524640 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | excitotoxicity | Q901117 |
| P304 | page(s) | 135-146 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo | |
| P478 | volume | 78 |
| Q32134036 | A dinucleotide deletion in amyloid precursor protein (APP) mRNA associated with sporadic Alzheimer's disease results in efficient secretion of truncated APP isoforms from neuroblastoma cell cultures. |
| Q42737591 | Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer m |
| Q28513133 | Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein |
| Q35216177 | Aging, Alzheimer's, and APOE genotype influence the expression and neuronal distribution patterns of microtubule motor protein dynactin-P50 |
| Q36005686 | All in the Family: How the APPs Regulate Neurogenesis |
| Q43565735 | Altered expression of glutamate transporters under hypoxic conditions in vitro |
| Q48239128 | Alzheimer's disease proteins in cerebellar and hippocampal synapses during postnatal development and aging of the rat. |
| Q52539012 | Amyloid beta peptide impaired carbachol but not glutamate-mediated phosphoinositide pathways in cultured rat cortical neurons. |
| Q33815736 | Amyloid precursor proteins are protective in Drosophila models of progressive neurodegeneration |
| Q46162628 | Amyloid protein precursor stimulates excitatory amino acid transport. Implications for roles in neuroprotection and pathogenesis |
| Q43850189 | Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. |
| Q41961695 | Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines |
| Q40971910 | Binding and selective detection of the secretory N-terminal domain of the alzheimer amyloid precursor protein on cell surfaces |
| Q48095480 | Coaccumulation of calcium and beta-amyloid in the thalamus after transient middle cerebral artery occlusion in rats |
| Q94361807 | Cycle on Wheels: Is APP Key to the AppBp1 Pathway? |
| Q36329164 | Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies. |
| Q42431887 | Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease |
| Q35589042 | Differential proteomic and behavioral effects of long-term voluntary exercise in wild-type and APP-overexpressing transgenics. |
| Q41734485 | Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease |
| Q40922286 | Effect of HIV-1 gp41 peptides on secretion of beta-amyloid precursor protein in human astroglial cell line, T98G. |
| Q46782480 | Effect of general anesthetics on amyloid precursor protein and mRNA levels in the rat brain |
| Q34625154 | Effects of the SARM ACP-105 on rotorod performance and cued fear conditioning in sham-irradiated and irradiated female mice |
| Q48351914 | Estrogen attenuates over-expression of beta-amyloid precursor protein messager RNA in an animal model of focal ischemia |
| Q73074470 | Expression of beta-amyloid precursor and Bcl-2 proto-oncogene proteins in rat retinas after intravitreal injection of aminoadipic acid |
| Q41671941 | Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. |
| Q73453669 | Expressions of amyloid precursor protein, synaptophysin and presenilin-1 in the different areas of the developing cerebellum of rat |
| Q36173031 | Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene |
| Q36950047 | Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury |
| Q35593776 | Genetic programming by the proteolytic fragments of the amyloid precursor protein: somewhere between confusion and clarity |
| Q90260172 | HIV and Alzheimer's disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein |
| Q35679568 | Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway. |
| Q42495568 | Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine |
| Q37692508 | Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection |
| Q48184379 | Induction of presenilins in the rat brain after middle cerebral arterial occlusion |
| Q28138617 | Inflammation and Alzheimer's disease |
| Q48476226 | Intraneuronal amyloid precursor protein (APP) and appearance of extracellular beta-amyloid peptide (abeta) in the brain of aging kokanee salmon |
| Q40015743 | Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS. |
| Q41859645 | Late Simian virus 40 transcription factor is a target of the phosphoinositide 3-kinase/Akt pathway in anti-apoptotic Alzheimer's amyloid precursor protein signalling |
| Q43772941 | Locally reduced levels of acidic FGF lead to decreased expression of 28-kda calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease |
| Q34317899 | Mechanisms by which metals promote events connected to neurodegenerative diseases |
| Q48393631 | Mice expressing human mutant presenilin-1 exhibit decreased activation of NF-kappaB p50 in hippocampal neurons after injury |
| Q42495065 | Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. |
| Q44795511 | Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. |
| Q77343222 | Neuronal death and survival in two models of hypoxic-ischemic brain damage |
| Q28587148 | No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice |
| Q46529938 | Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. |
| Q24633831 | Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies |
| Q37813307 | Resveratrol commonly displays hormesis: occurrence and biomedical significance |
| Q37956562 | Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging |
| Q35036675 | Signal transduction and neurosurvival in experimental models of brain injury |
| Q40340003 | Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation. |
| Q43681037 | The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. |
| Q43823404 | The immunosuppressant drug FK506 is a potent trophic agent for human fetal neurons |
| Q37845036 | The many substrates of presenilin/γ-secretase |
| Q47343852 | The non-peptidic δ-opioid receptor agonist Tan-67 mediates neuroprotection post-ischemically and is associated with altered amyloid precursor protein expression, maturation and processing in mice. |
| Q40674513 | The receptor-bound N-terminal ectodomain of the amyloid precursor protein is associated with membrane rafts. |
| Q40963012 | The role of the protein glycosylation state in the control of cellular transport of the amyloid beta precursor protein |
| Q34385977 | Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? |
| Q46229748 | Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. |
| Q48628855 | Visualization of APP dimerization and APP-Notch2 heterodimerization in living cells using bimolecular fluorescence complementation |
| Q36400886 | Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis |
Search more.